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Polycomb repressive complexes 1 and 2 (PRC1 and
PRC2) control cell identity by establishing facultative
heterochromatin repressive domains at common
sets of target genes. PRC1, which deposits H2Aub1
through the E3 ligases RING1A/B, forms six bio-
chemically distinct subcomplexes depending on
the assembled PCGF protein (PCGF1–PCGF6); how-
ever, it is yet unclear whether these subcomplexes
have also specific activities. Here we show that
PCGF1 and PCGF2 largely compensate for each
other, while other PCGF proteins have high levels of
specificity for distinct target genes. PCGF2 associ-
ates with transcription repression, whereas PCGF3
and PCGF6 associate with actively transcribed
genes. Notably, PCGF3 and PCGF6 complexes can
assemble and be recruited to several active sites
independently of RING1A/B activity (therefore, of
PRC1). For chromatin recruitment, the PCGF6 com-
plex requires the combinatorial activities of its
MGA-MAX and E2F6-DP1 subunits, while PCGF3 re-
quires an interaction with the USF1 DNA binding
transcription factor.
INTRODUCTION
The precise control of specific active and repressed transcrip-
tional states is at the basis of first establishing and then maintain-
ing cellular identity (Bracken and Helin, 2009; Orkin and Hoched-
linger, 2011). The Polycomb group (PcG) protein family provides
the major repressive mechanism for defining facultative hetero-
chromatin (Bernstein et al., 2006), an essential step for both
embryogenesis and homeostatic development of adult tissues
(Aloia et al., 2013; Avgustinova and Benitah, 2016). Polycomb
proteins exert their functions in two large multiprotein repressive
complexes, PRC1 and PRC2, which are defined by specificMolecular Cell 74, 1037–1052,
This is an open access article undcore activities that modify histone proteins. PRC2 deposits
mono-, di-, and tri-methylation on the lysine 27 of histone H3
(H3K27me1/me2/me3), catalyzed by the EZH1/2 methyltrans-
ferases (Ferrari et al., 2014; Margueron et al., 2008; Shen et al.,
2008); PRC1 mono-ubiquitinates histone H2A lysine 119
(H2Aub1), which is catalyzed by the E3 ligase RING1A or RING1B
(de Napoles et al., 2004; Endoh et al., 2008). These two activities
control common regulatory pathways by co-associating to a large
extent at the sameset of target genes (SimonandKingston, 2013).
Although core enzymatic activities are conserved, PRC1 and
PRC2 form distinct subcomplexes defined by the association
of ancillary subunits (Scelfo et al., 2015). In PRC1, RING1A/B
can interact with one of six distinct, mutually exclusive members
of the PCGFprotein family (PCGF1–PCGF6), thereby creating six
distinct PRC1 subcomplexes (PRC1.1–PRC1.6) that dictate the
recruitment of specific ancillary subunits with diverse functional
properties (Di Croce and Helin, 2013). Importantly, PCGF2 and
PCGF4, or PCGF3 and PCGF5, independently assemble bio-
chemically identical complexes bearing redundant functional
properties (Gao et al., 2012). Reasonably, up to four major activ-
ities for PRC1 could exist and be active in the same cells, in close
relationship with PRC2, but with potentially distinct functions
(Pasini and Di Croce, 2016).
PRC1.2 and PRC1.4 are also termed the canonical PRC1
complexes (and the other subcomplexes, non-canonical),
based on H3K27me3 recognition deposited by PRC2 (Scelfo
et al., 2015). Specifically, the CBX proteins in PRC1.2/PRC1.4
(not present in the other subcomplexes; Gao et al., 2012)
bind the H3K27me3 moiety via their chromodomain (Cao
et al., 2002; Fischle et al., 2003; Min et al., 2003). How non-ca-
nonical subcomplexes are recruited to chromatin remains less
well understood. Recruitment of PRC1.1 depends on its
KDM2B subunit, which can recognize unmethylated CpG
islands (Blackledge et al., 2014). The PRC1.6 complex contains
different proteins with DNA binding activity (E2F6-DP1 and
MGA-MAX dimers) that could allow direct binding to DNA
(Gao et al., 2012). In contrast, the PRC1.3 and PRC1.5 com-
plexes contain no subunits with defined DNA or chromatin
binding properties, and their recruitment mechanisms remain
unclear.June 6, 2019 ª 2019 The Authors. Published by Elsevier Inc. 1037
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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The activities of non-canonical PRC1 complexes can promote
the recruitment and/or stabilization of PRC2 to chromatin (Black-
ledge et al., 2014; Farcas et al., 2012). This involves the intrinsic
ability of PRC2 to bind H2Aub1 deposited by RING1A/B (Cooper
et al., 2016; Kalb et al., 2014).
Loss of RING1A/B activity results in pre-implantation lethality
at the two-cell stage (Posfai et al., 2012). All distinct PCGF activ-
ities play major but distinct roles in development (Akasaka et al.,
2001; Almeida et al., 2017; Endoh et al., 2017) (http://www.
mousephenotype.org/data/genes/MGI:1917087). Indeed, none
of them independently reproduce the loss of RING1A/B activity,
suggesting that distinct PCGF activities may act together to
determine RING1A/B biological functions. In this context,
several questions still remain unanswered. How are the activities
of the distinct PRC1 subcomplexes regulated? Do they act
redundantly to control similar pathways, or do they (also) have
specific functional features?
Here, we provide a comprehensive dissection of the functional
landscape of PCGF proteins, characterizing the crosstalk among
the different complexes, their relationship with PRC2 activity,
and the recruitment mechanisms that mediate their interactions
with chromatin andDNA. By combining the development of high-
ly specific PCGF1-6 antibodies with the generation of KOmouse
embryonic stem cells (ESC) lines, we mapped the physiological
genome-wide occupancy of all PRC1 subcomplexes to deter-
mine their functional control. We show that PCGF proteins retain
high levels of binding specificity, with little crosstalk among the
different complexes with the exception of PCGF1 and PCGF2,
which displayed extensive functional overlap. We demonstrate
that, while PCGF1 and PCGF2 activities are strongly linked
with transcriptional repression, PCGF3 and PCGF6 are mainly
associated with active transcriptional states, even in the
absence of RING1A/B recruitment. Importantly, the PCGF3-
and PCGF6-containing complexes did not require RING1A/B
for their assembly and recruitment to chromatin, providing evi-
dence that both complexes are recruited to target genes by
intrinsic and specific DNA binding modules.
RESULTS
Distinct PRC1 Subcomplexes Regulate Specific Sets
of Target Genes
We analyzed both transcription levels and mass spectrometry to
determine the relative amounts of distinct PRC1 subcomplexes
active in ESCs and found that the PCGF6- and PCGF2-contain-
ing complexes were the most abundant forms of PRC1 (Figures
S1A and S1B). PCGF4 and PCGF5 were only present in traceFigure 1. PCGFs Show Specificity in Target Gene Occupancy
(A) ChIP-qPCR analysis for the indicated PCGF proteins at selected target regions
for ChIP assay. ChIP enrichments are normalized to input. Data represent mean
(B) Genomic snapshots of the indicated ChIP-seq profiles at selected gene loci
(C) ChIP-seq cumulative enrichment deposition centered at peak summit for the
(D) Percentage of co-occupancy of the target genes identified for each indicated P
represent 14% or more of the total PCGF targets are shown in the legend.
(E) Genome-wide functional annotation of peaks generated from the indicated ChI
annotated TSS, and the downstream regions as the first 3 kb after the TES.
(F) ChIP-qPCR analysis for the indicated PCGF proteins at selected target region
See also Figure S1 and Tables S2 and S3.amounts, consistent with their poor expression in ESCs. These
results agreed with previous measurements (Kloet et al., 2016)
and further showed that the functional PRC1 subcomplexes in
ESCs are defined by the presence of PCGF1, PCGF2, PCGF3,
and PCGF6, confirming that all four functionally distinct forms
of PRC1 are present in ESCs.
We developed highly specify antibodies for each PCGF protein
and engineered ESC lines to individually create Pcgf1 and Pcgf6
knockouts (KO) and Pcgf2/4 and Pcgf3/5 double-KO (STAR
Methods; Table S1) to avoid any potential compensatory effects
of redundant PCGF proteins (Figures 1A and 1B) and mapped
the PCGF1, PCGF2, PCGF3, and PCGF6 occupancies along the
ESC genome by ChIP-seq assays (Figures 1B and 1C). We found
that PCGF1 had the most extensive binding repertoire, with 5,261
target genes, followed by PCGF2 (3,522), PCGF6 (2,822), and
PCGF3 (185) (Figure 1D). These differences were not due to
diverse antibodies efficiencies (Figures S1C and S1D) and did
not echo the relative abundance of subcomplexes (Figure S1B).
Similar to RING1B, all PCGF proteins preferentially associated to
promoter elements (> 75%; Figure 1E) and showed affinity for
high CpG dinucleotides density (Figure S1E). PCGF2 occupied
broader regions while other PCGF proteins displayed sharper
associations, suggesting different modes of chromatin interac-
tions (Figure S1F). By overlapping the enriched genomic regions
of each PCGF protein, we found that more frequent combinations
of promoter co-occupancy emerged (e.g., PCGF1/2 and PCGF1/
2/6) (Figures 1D and S1G). However, these results demonstrated
that PCGF proteins also retain high specificity in genomic occu-
pancy, as confirmed by ChIP-qPCR analysis (Figure 1F).
PCGF Proteins Associate with Distinct Functional
Domains
We next examined whether distinct PCGF proteins associate
to promoter regions that have similar or unique functional
properties. First, we defined promoters exclusively-occupied
and co-occupied by different PCGFs (Figures 2A and S2A;
Tables S2 and S3). Then, we analyzed, on those regions,
the presence of general components of the two Polycomb
machineries (SUZ12, RING1B, RYBP, and CBX7); WDR5,
component of several multiprotein complexes including
PRC1.6, COMPASS, and basal transcriptional machineries
(Guarnaccia and Tansey, 2018); the unmethylated CpG binding
protein KDM2B (Farcas et al., 2012); and histone post-
translational modifications (PTMs) associated with activation
(H3K4me3 and H3K36me3) or repression (H3K27me3 and
H2Aub1) (Figures 2A and S2A). We found that PCGF2 was
always associated with a Polycomb repressive signature andin wild-type (WT) and in indicated Pcgf KOmouse ESCs. IgG served as control
± SEM.
performed as in (A).
indicated PCGF proteins performed as in (A).
CGF protein with respect to the other datasets. For simplicity, just regions that
P-seq analyses. Promoters are defined as the region around ±2.5 kb frommm9-
s in the indicate mESC lines.
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that, in the absence of PCGF2, PCGF3, and PCGF6, were asso-
ciated with a transcriptional permissive status (e.g., high
H3K4me3 and H3K36me3), with PCGF3 target genes showing
the highest transcriptional activity (Figures 2B and 2C). Similarly,
only PCGF1 unique targets, devoid of PCGF2 co-occupancy,
displayed a permissive transcriptional activity (Figure 2C),
strengthening the correlation between PCGF2 binding and tran-
scriptional repression. These results were further confirmed by
transcriptional RNA-seq analyses (Figure 2D).
Wenextassayed the transcriptionalpropertiesofPCGFproteins
by independent tethering (as GAL4-PCGF chimeras) to an ectopic
artificial promoter thatcontrolled the luciferasegene (asa readout).
PCGF2 and PCGF4 strongly repressed luciferase expression,
while PCGF3 or PCGF5 activated it (Figure 2E), consistent with
their association with repressed and actively transcribed genes,
respectively (Figure 2D). PCGF6 strongly repressed luciferase
expression (Figures2Eand2F), suggesting that thiscomplexcould
have repressivepropertiesalsoat its transcribed targetpromoters.
MSanalysis of theGal4-PCGF fusionsdemonstratednormal com-
plexes assembly (FigureS2B; Table S4) to all previously described
PRC1 partner proteins (Gao et al., 2012).
Gene ontology for PCGF2-associated genes showed a signifi-
cant enrichment for development-related processes, irrespective
of their co-occupancy with other PCGF proteins (Figure S2C). In
contrast, PCGF3- and PCGF6-associated genes were enriched
for distinct ontologies related to autophagy or meiosis/spermato-
genesis, respectively, denoting distinct functional properties
(Figure S2C).
PCGF Loss Does Not Result in Functional Compensation
but Influences PRC1 Subcomplex Activity
To determine whether PRC1 subcomplexes had specific
compensatory features, we quantified the chromatin association
of PCGF1, PCGF2, PCGF3, and PCGF6 in all the Pcgf KO ESC
lines by ChIP-seq (Figures 3A). PCGF protein levels and core
components of PRC1 and PRC2 remained overall stable (Figures
S3A and S3B). Consistently, PCGF proteins’ occupancy was not
altered at their specific binding sites (Figures 3B, S3C, and S3D),
an effect that was confirmed using a reference genome (ChIP-
RX) for signal normalization (Figures S4A and S4B). PCGF pro-
teins did not compensate for each other. For instance, PCGF2
did not bind at PCGF6 target sites in Pcgf6 KO ESCs (FiguresFigure 2. Specific PCGF Activities Define Activating and Repressive M
(A) Heatmaps representing the normalized ChIP-seq intensities for the indicated P
co-occupancy in wild-type (WT)mESCs. H3K36me3 intensity was analyzed over t
were obtained from Morey et al. (2013) and KDM2B from Farcas et al. (2012).
(B) Pearson correlation of ChIP-seq signal over the promoter regions (±4 kb from
(C) Average deposition profile of H3K36me3 in WT mESCs over the gene body (fr
occupied by at least two PCGF proteins (right panel), as indicated.
(D) Boxplots showing the expression levels obtained from RNA-seq analyses pe
H3K4me3-positive loci served as controls for repressed and active promoters, r
(E) Upper panel: GAL4-TK-luciferase reporter system of 293TRex clones expres
panel: Luciferase activity triggered by Gal4-fusion recruitment at GAL4-TK-Luci
Luciferase activity was normalized to protein content. Data represent mean ± SE
(F) Upper panel: GAL4-TK-luciferase reporter system of 293TRex clones express
panel: Luciferase assay (as in E) with PCGF6 N-terminally or C-terminally fused t
relative to the empty control and was normalized to protein content. Data repres
See also Figure S2 and Table S4.3B, S4A, and S4B). Similarly, PCGF1 was not affected at
PCGF2-target regions in Pcgf2/4 KO ESCs and vice versa. Over-
all, these data showed that, in absence of specific PCGF activ-
ities, target specificity is largely maintained.
We next quantified binding of RING1B (for PRC1) and SUZ12
(for PRC2), as well as deposition of H2Aub1 and H3K27me3, at
each specific group of targets (Figures 3C and S4C). Regions
occupied by PCGF2, regardless of which PCGF protein was
co-associated, presented much higher RING1B and SUZ12 as-
sociation as well as H2Aub1 and H3K27me3 deposition than
those occupied by PCGF3 and PCGF6 (Figures 3C and S4C).
RING1B association was reduced at PCGF2 binding sites in
Pcgf2/4 KO, as well as at PCGF6 binding sites in Pcgf6 KO.
PCGF1 loss had no effect on RING1B association, likely due to
PCGF2 compensation. However, RING1B association was only
partially lost in Pcgf2/4 KO, likely compensated by PRC1.1.
H2Aub1 deposition was maintained at targets in Pcgf1 and
Pcgf2/4 KOs, suggesting full compensation between PCGF1
and PCGF2. Differently, RING1B association and H2Aub1 depo-
sition were specifically lost at PCGF3/6 or PCGF6 targets in
Pcgf6KOESCs (Figures 3C andS4C). Together, these results re-
vealed that PCGF1 and PCGF2 could compensate for each other
specifically at their repressed co-occupied sites but that PCGF6
independently controlled RING1B activity and PRC2 recruitment
at sites with substantial transcriptional activity.
PCGF1/2/4 Module Preserves H2Aub1 Deposition at
Repressed Sites but Is Dispensable for ESC Viability
Based on these findings, we defined PCGF1/2/4 activity as the
PRC1 repressive module and PCGF3/5/6 as the PRC1 activating
module, and generated Pcgf1/2/4 and Pcgf3/5/6 triple KO ESCs
(Figures S5A and S5B). While Pcgf1/2/4 KO showed no effects
on cell viability, Pcgf3/5/6 KO clones displayed severe morpho-
logical changes acquiring a flattened fibroblast-like shape (Fig-
ures 4A and S5C). Principal component analysis (PCA) from
RNA-seq profiles showed that the transcriptome from Pcgf1/2/
4 KO cells was largely unaltered as compared to wild-type,
Pcgf1 KO, or Pcgf2/4 KO ESCs (Figures 4B, 4C, S5D, and
S5E; Table S5). Loss of Pcgf6 alone induced significant pheno-
typic changes, in agreement with previous reports (Yang et al.,
2016), enhanced by concomitant loss of PCGF3/5 activities
(Pcgf3/5/6 KO). RNA-seq analyses showed alterations inodules
CGF proteins over ±4 kb around the TSS of the indicated loci stratified for PCGF
he entire gene length (from TSS to TES). CBX7 and RYBP datasets frommESCs
TSS) of annotated RefSeq coding genes (mm9).
om TSS to TES) of PCGF unique bound promoters (left panel) or promoters co-
rformed in WT mESC for the indicated PCGF target genes. H3K27me3- and
espectively.
sing inducible Gal4 (empty) or the indicated Gal4-PCGF fusion protein. Lower
ferase promoter is shown as the fold difference relative to the empty control.
M.
ing inducible Gal4 (empty) or the indicated Gal4-PCGF6 fusion protein. Lower
o the DNA binding domain of Gal4. The activity is shown as the fold difference
ent mean ± SEM.
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expression of genes implicated with various developmental pro-
cesses, overall highlighting a compromised ESC identity (Figures
4B, 4C, S5D, and S5E). However, this occurred in the absence of
a major induction of early differentiation programs (Figure S6)
(Hutchins et al., 2017). In particular, Pcgf3/5/6 KO ESCs were
characterized by extracellular matrix and cornification enriched
ontologies (Figure S7A; Table S6) that corresponded to a reorga-
nization of actin fibers (Figure 4A) and massive upregulation of
collagens and keratins (Figures S7B and S7C).
Combined loss of the PCGF1/2/4 resulted in complete
RING1B displacement and loss of H2Aub1 specifically at all
PCGF2-occupied loci (Figures 4D, 4E, S7D, and S7E), remaining
unaltered in Pcgf3/5/6 KOs (Figures 4F, 4G, S7F, and S7G). This
further correlated with decreased PRC2 (SUZ12) association
and reduced H3K27me3 deposition (Figures 4D, 4E, S7D, and
S7E). Lack of H2Aub1 deposition did not result in a significant
activation of these targets (Figures 4B and 4C). In contrast,
loss of PCGF6 led to diffuse gene upregulation (Figures 4B,
4C, and S7H), which occurs in absence of PCGF1/2 displace-
ment and loss of H2Aub1 from co-occupied promoters
(Figure 3B, S4C, S5A, and S5B). This supports Gal4-PCGF6
repressive activity and the H2Aub1-independent transcriptional
properties of PRC1 (Illingworth et al., 2015; Pengelly et al., 2015).
RING1A/B Mediates Complex Assembly and Chromatin
Binding for PCGF1 and PCGF2, but Not for PCGF3
and PCGF6
A detailed quantification of RING1B co-occupancy with each
PCGF protein showed that 70% of all RING1B binding sites
overlapped with at least one PCGF protein (Figure 5A). Approx-
imately 60%, 40%, and 80% of PCGF1-, PCGF6-, and PCGF3-
bound genomic loci, respectively, were not significantly enriched
for RING1B association (Figure 5B). This lack of RING1B co-
occupancy correlated with (1) a lack of repressive marks
(H3K27me3 or H2Aub1) and (2) an accumulation of an activating
signature (H3K4me3 and H3K36me3) (Figures S8A–S8E). These
observations suggested that RING1B was indeed absent from
these sites. To gain further evidence for the role of RING1B in
regulating different PCGF complexes functions, we performed
ChIP-seq analysis for each PCGF protein after RING1A/B loss
of function (LoF) using a Ring1A–/–; Ring1Bfl/fl; Rosa26::CreERT2
conditional mouse ESC line (Endoh et al., 2008) (termed herein
R1A KO-R1B FL). Treatment with 4-hydroxy tamoxifen (OHT)
conditionally deletes Ring1B, leading to complete loss of
RING1B expression within 48 hr (Figure S8F). ChIP-seq analysis
for PCGF1 and PCGF2 at 60 hr after OHT treatment showed
global displacement of both proteins from chromatin, demon-
strating that RING1A/B expression is essential for PCGF1/2
recruitment (Figures 5C, 5D, S8G, and S8H). PCGF2 levels
were strongly destabilized in the absence of RING1A/B, sug-
gesting that RING1A/B are required for the assembly of theFigure 3. PCGFs Are Specific with Little Compensatory Crosstalk
(A) Genomic snapshots of the indicated ChIP-seq profiles at selected target gen
(B and C) Boxplots of the normalized intensity profiles of ChIP-seq analyses for PC
SUZ12, or H3K27me3 (C), performed in WTmESCs, Pcgf1, Pcgf2/4, Pcgf3/5, or P
unique and co-occupied target genes, as indicated.
See also Figures S3 and S4.PRC1.2 complex (which mediates the stabilization of PCGF2)
(Figure S8F). In contrast, similar analyses for PCGF3 and
PCGF6 revealed that loss of RING1A/B expression did not affect
their genome-wide localization (Figures 5E and 5F). Together,
these results strongly suggested that while RING1A/B plays an
essential role in the assembly and recruitment of the PRC1.1
and PRC1.2 complexes, it is dispensable for PCGF3 and
PCGF6 chromatin association. This reinforces the possibility
that several PCGF3 and PCGF6 targets do not require
RING1A/B association.
E2F and the E-Box Motif Cooperate to Recruit the
PCGF6 Complex to Target Sites
To further explore the properties of the PRC1.6, we investi-
gated its biochemical and recruitment features. Co-immuno-
precipitation (coIP) analyses for PCGF6 in R1A KO-R1B FL
ESCs (treated or not with OHT) and Pcgf6 KO ESCs revealed
that, consistently with ChIP-seq results, components of the
PRC1.6 remained associated with PCGF6 even in the
absence of RING1A/B expression (e.g., L3MBTL2, MAX,
and WDR5) (Figure 6A). We performed de novo motif discov-
ery on PCGF6 peaks and found that MYC (E-box) and E2F
sites were the most enriched and represented DNA motifs
(Figure 6B). This strongly agrees with the presence of
E2F6-DP1 and MGA-MAX heterodimers among the compo-
nents of the PCGF6 complex (Hauri et al., 2016; Ogawa
et al., 2002). Indeed, PCGF6 occupancy in ESCs almost
completely overlapped with MGA genomic distribution (Stie-
low et al., 2018) (Figure S9A). This result was further
confirmed by ChIP-qPCR performed with MGA and E2F6 an-
tibodies (Figure S9B). To further explore the contribution of
these DNA binding activities in PCGF6 recruitment, we
knocked down MGA using different shRNA sequences (Fig-
ures S9C and S9D). Notably, PCGF6 was displaced from all
its target sites upon MGA downregulation, as shown by
ChIP analysis for PCGF6 (Figure 6C). However, in an ESC
line with a MGA C-terminal deletion of the HLH domain
(MgaDHLH), PCGF6 binding was only moderately affected
(2-fold; Figures 6D–6F). These results demonstrated that
E-box recognition was not sufficient to impair PCGF6 recruit-
ment but suggested that MGA has broader structural func-
tions in mediating proper PCGF6 complex assembly. CoIP
analysis for PCGF6 in both MgaDHLH ESCs or after Mga
shRNA-mediated knockdown revealed that the MGADHLH
mutation did not affect the association of PCGF6 with its
different interacting partners but that downregulation of
MGA expression disrupted the PCGF6 complex (Figure 6G).
We next tested whether the E2F6-DP1 dimer provided addi-
tional DNA binding affinity to the PCGF6 complex. We induced
loss of E2F6 or MAX expressing specific shRNAs in wild-type
orMgaDHLH mutant ESCs (Figures S9E and S9F) and analyzede loci, performed in WT and in the indicated Pcgf KO mESC clones.
GF1, PCGF2, PCGF3, or PCGF6 (B) and for RING1B, H2AK119ub1 (H2Aub1),
cgf6 KO ESC clones. Signal enrichment was calculated using a region ±4 kb at
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PCGF6 chromatin association by ChIP. The combined loss of
MGA and E2F6 DNA binding activities further reduced PCGF6
recruitment to its target sites (Figures 6D, 6E, 6H, S9G, and
S9H). This strongly suggests that E2F and E-box recognition
by intrinsic subunits of the PCGF6 complex mediates DNA bind-
ing specificity. It is important to highlight that PCGF6 bindingwas
clearly affected but not completely abolished by E2F6 shRNA
(Figures 6D, 6E, and 6H). Although this could be a consequence
of an incomplete loss of E2F6 expression (Figure S9F), this result
may also suggest that additional recruitment mechanisms (i.e.,
via L3MBTL2; Huang et al., 2018; Trojer et al., 2011) contribute
to recruiting the PCGF6 complex to its specific target loci.
USF1/2 Interactswith the PCGF3Complex andMediates
Its Chromatin Recruitment
PCGF3 associated with high specificity to a restricted number of
transcribed target promoters in a RING1A/B (PRC1)-independent
manner. As no evident DNA binding activities were previously
associated to the PCGF3 complex (Gao et al., 2012), we per-
formed de novo motif discovery analyses on PCGF3 peaks. The
only enriched motif perfectly matched an E-box variant corre-
sponding to the DNA binding site of USF1/2, an HLH-containing
transcription factor that forms a heterodimer similar to MYC-
MAX (Kiermaier et al., 1999) (Figure 7A). In accordance, ChIP-
seq analyses of USF1 in wild-type ESCs revealed a strong
USF1 enrichment at almost all PCGF3-bound loci (88%; Figures
7B–7D and S10A). This enrichment was specific for PCGF3 and
overlappedonlymarginallywith other PCGFbinding sites (Figures
7D and 7E). As USF1 has not been previously reported to interact
with PCGF3, we tested USF1–PCGF3 interaction using milder
coIP conditions after digesting DNA with benzonase. USF1
showed a clear DNA-independent association with the PCGF3
complex (Figures 7F and S10B). Size-exclusion chromatography
further confirmed this result: USF1 co-eluted in a high molecular
weight fractions (>650 kD) together with several components of
the PCGF3 complex (Figure 7G). We next downregulated Usf1
and Usf2 expression with different shRNAs in wild-type ESCs
(Figures S10C and S10D). ChIP-seq analysis under these condi-
tions showed that PCGF3 was displaced from all PCGF3 target
sites in the absence of USF1/2 expression (Figures 7H and 7I).
In contrast, DNA binding of USF1 was not affected by loss of
PCGF3 at target sites (Figures S10E and S10F). Together, theseFigure 4. PCGF1 and PCGF2 Compensate H2Aub1 Deposition at Spec
(A) Phalloidin immunofluorescence staining in wild-type, Pcgf1/2/4, and Pcgf3/5
(B) Principal component analysis of gene expression levels from RNA-seq analy
experimental replicates.
(C) Volcano plots of –log10 (p value) against log2 fold change representing the diffe
and WT for all protein coding genes (upper panels) and for PCGF1 and PCGF2 t
(D) Boxplots of normalized ChIP-seq intensity profiles of RING1B, H2AK119ub1
Pcgf1/2/4 KO mESC clones, over ±500 bp (or ±4 kb for H2Aub1 and H3K27me3
PCGF1/2 or PCGF1/2/6.
(E) Genomic snapshots of the ChIP-seq profiles quantified in (D) at selected target
Pcgf KO mESC clones.
(F) Boxplots of normalizedChIP-seq intensity profiles of RING1B, H2AK119ub1 (H
5/6 KO mESC clones over ±500 bp (or ±4 kb for H2Aub1 and H3K27me3) aroun
(G) Genomic snapshots of the ChIP-seq profiles quantified in (F) at selected comm
Pcgf KO mESC clones.
See also Figures S5, S6, and S7 and Tables S5 and S6.results demonstrated that USF1 and USF2 function as DNA bind-
ing hubs that mediate recruitment of the PCGF3 complex to DNA.
DISCUSSION
PCGF Proteins Have High Specificity for Target Genes
Our data provide the first genome-wide analysis of different PCGF
protein activities at a physiological level. These results clearly
showed that PCGF proteins display high binding specificity with
little functional overlap, with the exception of PCGF1 and
PCGF2. PCGF1 has a broad pervasive binding at a large set of
CpG-rich promoters, which correlates with RYBP binding and
with the broad occupancy of KDM2B. Importantly, H2Aub1 depo-
sition was affected only when loss of PCGF1 and PCGF2/4 were
combined, suggesting full enzymatic compensation of these
complexes without altering their overall recruitment. Based on
these results, we speculate that PCGF1 and PCGF2 act redun-
dantly and enzymatically engage the same target sites in the
absence of any evident competition. PCGF6 also showed sub-
stantial overlap with PCGF1/2 but with amarginal role in compen-
sating H2Aub1 deposition at these sites. The remaining PCGF6
sites essentially lacked co-association of any other PCGFprotein,
and loss of PCGF6 did not result in significant cross-compensa-
tions. Finally, PCGF3 had few but very specific binding sites at
promoters, and it only marginally overlapped with PCGF6.
Together, these results highlight the functional specificity of the
distinct PRC1 subcomplexes, demonstrating that while PRC1.1
and PRC1.2 cooperate to regulate the same pathways, PRC1.3
and PRC1.6 retain high target specificity and little crosstalk with
the activity of the other complexes. Surprisingly, combined loss
of PCGF1/2/4 and lack of H2Aub1 deposition at repressed genes
did not induce a significant transcriptional reactivation. In
contrast, loss of PCGF6 activity resulted in a clear reactivation
of these targets as well as of transcribed PCGF6 unique targets
devoid of PCGF1/2 co-association. Together, these results sug-
gest that PCGF6 plays a general major role in repression. Further-
more, this occurred at PCGF1/2 co-occupied promoters without
loss of H2Aub1. This highlights a marginal role of H2Aub1 in
repression that supports previous reports that challenged the
role of H2Aub1 in regulating PcG spatiotemporal control of target
genes expression during development (Illingworth et al., 2015;
Pengelly et al., 2015).ific Targets and Are Dispensable for ESC Viability
/6 triple KO mESC. Scale bars correspond to 30 mm.
sis performed in WT mESCs and in the indicated KOs. Dashed lines enclose
rences in gene expression between Pcgf1/2/4 andPcgf3/5/6 KOmESC clones
argets or PCGF3 and PCGF6 targets, respectively (bottom panels).
(H2Aub1), SUZ12, and H3K27me3 performed for WT or Pcgf1, Pcgf2/4, and
) around the TSS of target genes unique for PCGF3 or PCGF6, or common to
gene loci (common or unique, as indicated), performed inWT and the indicated
2Aub1), SUZ12, andH3K27me3 performed inWT orPcgf6,Pcgf3/5, andPcgf3/
d the TSS of unique or common target genes (as indicated).
on or unique target gene loci (as indicated), performed in WT and the indicated
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PRC1 Subcomplexes Comprise Repressive or Activating
Modules
Our results revealed that the presence of PCGF2 always corre-
lated with full transcriptional repression, regardless of which
PCGF protein was co-associated, at target loci involved in devel-
opmental processes. This is in line with the co-association of a
classical Polycomb signature characterized by abundant
H2Aub1 deposition, PRC2 binding, and high H3K27me3 levels.
In contrast, PCGF6 unique targets presented a permissive tran-
scriptional state, whereas PCGF3 targets a full transcriptional
activity. In addition, our data show that PCGF3 and PCGF6
can both exist in a complex in the absence of RING1A/B associ-
ation, which correlates with lack of classical PcG chromatin
signature. While PCGF6-bound promoters presented a much
lower enrichment, PCGF3 sites showed nearly undetectable
RING1B andH2Aub1 levels at target loci (enriched for autophagy
and lysosomal activity ontologies). However, it is also possible
that the high transcriptional status of these targets per se pre-
vents accumulation of repressive marks. Overall, these data
showed that the levels of PRC1.2 at target sites correspond
well to transcriptional activity, while recruitment of PCGF1,
PCGF3, and PCGF6 complexes may be less dependent on the
transcriptional status of their target genes. This relates to the
passive models of PRC2 recruitment proposed by the Helin
and Bernstein laboratories, showing that PRC2 promiscuously
binds unmethylated CpG islands until it is excluded by active
transcription (Mendenhall et al., 2010; Riising et al., 2014).
Indeed, both PRC1.1 and PRC1.2 have (direct or indirect) affin-
ities for CpG-dense regions: KDM2B provides a direct affinity
for unmethylated CpGs to PRC1.1 (Farcas et al., 2012), and
the H3K27me3 deposited by PRC2 provides a docking site for
PRC1.2 (Cao et al., 2002; Fischle et al., 2003; Min et al., 2003).
In contrast, the requirement of specific DNA binding activities
of PCGF3 and PCGF6 complexes to actively transcribed genes
may also suggest distinct biological functions that are different
from PCGF1/2.
PCGF3 and PCGF6 Activity Is Linked to Transcription
Activation and Does Not Require RING1A/B Association
While PCGF3 and PCGF5 activated transcription in an artificial
assay, PCGF6 behaved as a repressor, in apparent contradic-
tion with its physiological association to actively transcribed
targets. Since PCGF6 is recruited to DNA by E-box recognition,Figure 5. PCGF3 and PCGF6 Activities Are Independent of RING1A/B
(A) Percentage of occupancy of the different PCGF proteins at RING1B-bound p
(B) Percentage of overlap of RING1B, SUZ12, CBX7, and RYBP at the indicated
(C) Upper panel: Genomic snapshots of PCGF1 ChIP-seq profiles at selected
Ring1A–/–;Ring1B–/– (R1A KO-R1B KO) mESCs. Bottom left: Heatmap showing th
KO mESC over ±2.5 Kb of PCGF1/RING1B and PCGF1/2/RING1B common targ
mulative quantification of the heatmaps and PCGF1 ChIP-qPCR analysis at select
ChIP enrichments were normalized to input. Data represent mean ± SEM.
(D) As in (C), for PCGF2 ChIP-seq profiles analyzed at the indicated PCGF2-spe
(E) Upper panel: Genomic snapshots of PCGF3 ChIP-seq profiles at selected g
Bottom left: Heatmap showing the normalized signal of PCGF3 ChIP-seq in R1A
common target loci and PCGF3 unique target loci. Bottom right: Cumulative quan
performed in the same ESCs. IgG served as ChIP negative control. ChIP enrichm
(F) As in (E), for PCGF6 ChIP-seq profiles analyzed at the indicated PCGF6-spec
See also Figure S8.we envisioned an antagonisticmechanismbetween PCGF6 and
MYC. MYC shares a large fraction of PCGF6 targets, and, upon
loss of PCGF6 functions, a substantial set of transcribed
PCGF6 targets increased their transcriptional activity. This sug-
gests that PCGF6 may function as ‘‘attenuator’’ of transcription
via yet-uncharacterized mechanisms of regulation that may not
involve H2Aub1 deposition. We found that RING1A/B activity
was dispensable for both assembly and chromatin recruitment
of the PCGF3 and PCGF6 complexes, which could provide
insight to a not-yet-identified mechanism regulating the activity
of these complexes at target sites in the absence of RING1A/B.
Indeed, RING1B recruitment and H2Aub1 deposition were very
low at uniquely PCGF6 target sites and were only barely detect-
able at PCGF3 sites. Based on the crystal structure of the
RING1B-PCGF4 (BMI1) heterodimer, PCGF proteins should
interact with RING1A/B via dimerization of their respective
RING domains (Buchwald et al., 2006). In fact, while this inter-
action is critical for PRC1.1 and PRC1.2 complexes, it seems
to have a poor impact on assembly or recruitment of the
PRC1.3 and PRC1.6. Only RYBP association was dependent
on RING1A/B, suggesting that RING1A/B-RYBP are recruited
to the PCGF3 and PCGF6 complexes as a separate module.
How these interactions are regulated, and whether they play
any role in the biological function of these complexes, remains
to be clarified.
PCGF6 Is Recruited to DNA by Cooperative Binding to
E2F and E-Box Elements
Our data showed that the PCGF6 complex’s affinity for DNA
comes from the DNA binding activities of its distinct subunits.
The complete displacement of PCGF6 from chromatin upon
loss of MGA expression agrees with previous reports (Endoh
et al., 2017; Stielow et al., 2018) but was a consequence of com-
plex destabilization rather than a loss of DNA interaction. Thus,
MGA also plays an important role as a scaffold to assemble
the PCGF6 complex, very similar to the role of L3MBTL2 in this
same complex (Stielow et al., 2018). Indeed, a minimal C-termi-
nal truncation of the DNA binding domain of MGA can still
assemble a normal PRC1.6, only partially reducing its chromatin
recruitment. In these conditions, the additional loss of E2F6
further displaced the PCGF6 complex from chromatin, demon-
strating that both DNA binding activities are required for efficient
PCGF6 complex target recognition.romoters.
PCGF-bound promoters.
genomic regions performed in Ring1A–/–;Ring1Bfl/fl (R1A KO-R1B FL) and
e normalized signal of PCGF1 ChIP-seq in R1A KO-R1B FL and R1A KO-R1B
et loci, as well as PCGF1 and PCGF1/2 unique target loci. Bottom right: Cu-
ed regions performed in the samemESCs. IgG served as ChIP negative control.
cific targets.
enomic regions performed in R1A KO-R1B FL and R1A KO-R1B KO mESC.
KO-R1B FL and R1A KO-R1B KO mESCs over ±2.5 Kb of PCGF3/RING1B
tification of the heatmaps and PCGF3 ChIP-qPCR analyses at selected regions
ents were normalized to input. Data represent mean ± SEM.
ific targets.
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PCGF3 Is Recruited to Chromatin by Its Interaction with
USF1/2 DNA Binding Transcription Factors
Among the PRC1 subcomplexes, only the PRC1.3 and
PRC1.5 complexes do not contain biochemical modules that
provide specific affinity for chromatin states (e.g., CBX proteins)
and/or DNA elements (e.g., KDM2B, MGA, or E2F6). Through
genome-wide location analysis, we identified a strong enrich-
ment for the USF1/2 DNA binding motif that corresponds to a
variant E-box that contains a thymidine at the 50 of the canonical
CACGTG E-BOX motif recognized by MYC (TCACGTG). This
may explain the moderate but specific enrichment of PCGF3 at
some PCGF6 sites. We further demonstrate that USF1 interacts
with PCGF3 independently of DNA and that its expression was
essential for the recruitment of the PCGF3 complex to all its
target sites. USF1/2 is functionally linked with active chromatin
states (Pognonec and Roeder, 1991) and, together with the
role of the PCGF3 component AUTS2 in mediating P300 recruit-
ment (Gao et al., 2014), directly links the PCGF3 complex to tran-
scriptional activation. It remains unclear how this activatory role
is linked with PCGF3/5 mediated regulation of X chromosome
inactivation (Almeida et al., 2017). In the future, it would be
very interesting to dissect the biochemical basis of PCGF3-
USF1 interaction and to know how it is regulated to provide func-
tional specificities.
Altogether, our results provide a first comprehensive analysis
of the different PRC1 subcomplexes activities, uncovering their
functional specificities that classify them in either repressive or
activating modules with defined specific mechanisms of recruit-
ment. Importantly, our data further demonstrate that RING1A/B
activity is not essential for the assembly or chromatin recruitment
of all PRC1 subcomplexes, suggesting a new potential mecha-
nism of regulation for PCGF3/5 and PCGF6. Based on these
latter findings, we speculate that PCGF1 and PCGF2 exert Poly-
comb-related functions, while PCGF3/5 and PCGF6 activities
can also exist in functional forms unrelated to classically defined
Polycomb activities.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:Figure 6. PCGF6 Requires Cooperative E2F and E-Box Recognition fo
(A) Western blot analyses using the indicated antibodies in PCGF6 immunopreci
served as loading control.
(B) De novo motif discovery analysis performed underneath the summit of PCG
binding motifs are shown together with p values.
(C) PCGF6 ChIP-qPCR analyses on mESC expressing scrambled (sh Ctrl) orMga
ChIP negative control. ChIP enrichments are normalized to input. Data represen
(D) Normalized intensity profiles and heatmap of PCGF6 binding in WT mESCs o
mutant around ±2.5 kb of the TSS of common and unique target loci.
(E) Boxplots of the normalized intensity profiles of ChIP-seq analyses for PCGF6 in
MgaDHLH mutant over ±500 bp respective to the TSS of common and unique ta
(F) Genomic snapshots of the PCGF6 ChIP-seq profiles at selected genomic reg
(G) Western blot analyses using the indicated antibodies in PCGF6 immunoprecip
IgG served as an unrelated control antibody. Input is shown as loading control.
(H) PCGF6 ChIP-qPCR analysis on WT mESCs and MgaDHLH mESCs expres
negative region (unrel). IgG served as ChIP negative control. ChIP enrichments a
See also Figure S9.d KEY RESOURCES TABLE
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B Plasmid Generation
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit anti-Pcgf1 this study N/A
Rabbit anti-Pcgf2 this study N/A
Rabbit anti-Pcgf3 this study N/A
Rabbit anti-Pcgf6 this study N/A
Rabbit anti-Ring1b Pasini laboratory N/A
Rabbit anti-Wdr5 Pasini laboratory N/A
Mouse anti-Vinculin Pasini laboratory N/A
Rabbit anti-Rybp Millipore Cat# AB3637; RRID: AB_2285466
Rabbit anti-Cbx7 Abcam Cat# ab21873; RRID: AB_726005
Rabbit anti-Suz12 Cell Signaling Technology Cat# 3737S; RRID: AB_2196850
Rabbit anti-H3K27me3 Cell Signaling Technology Cat# C36B11; RRID: AB_2616019
Rabbit anti-H3K36me3 Cell Signaling Technology Cat# 4909BF; RRID: AB_2616016
Rabbit anti-H3K4me3 Active Motif Cat# 39159; RRID: AB_2615077
Rabbit anti-H2AK119ub1 Cell Signaling Technology Cat# 8240; RRID: AB_10891618
Rabbit anti-L3mbtl2 Active Motif Cat# 39570; RRID: AB_2615062
Rabbit anti-Max Santa Cruz Biotechnology Cat# sc-197; RRID: AB_2281783
Mouse anti-Usf1 Santa Cruz Biotechnology Cat# sc-101197; RRID: AB_1131108
Rabbit anti-Auts2 ProteinTech Cat# 25001-1-AP
Rabbit anti-Csnk2b ProteinTech Cat# 20234-1-AP
VeriBlot IP Detection Reagent (HRP) Abcam Cat# ab131366
Rabbit anti-E2F6 Abcam Cat# ab53061
Rabbit anti-MGA Bethyl Cat# A302-864A
Rabbit anti-GAL4 Santa Cruz Biotechnology Cat# sc-577
Bacterial and Virus Strains
STBL3 Thermo Fisher Scientific Cat# C737303
TOP10 Thermo Fisher Scientific Cat# C404010
BL-21 Thermo Fisher Scientific Cat# C600003
Experimental Models: Cell Lines
Human: HEK293T ATCC ATCC CRL-3216
Human: HEK293T 5XGal4TK-Luc-neo Flp-In Pasini et al., 2010 N/A
Mouse: ES cell line Ring1A/;Ring1Bfl/fl;
Rosa26::CreERT2
Endoh et al., 2008 N/A Strain of origin 129P2/Ola
Mouse: ES cell line E14 Pasini laboratory N/A Strain of origin 129P2/Ola
Mouse: ES cell line E14 Pcgf1 / this study N/A Strain of origin 129P2/Ola
Mouse: ES cell line E14 Pcgf2 / this study N/A Strain of origin 129P2/Ola
Mouse: ES cell line E14 Pcgf3/5/ this study N/A Strain of origin 129P2/Ola
Mouse: ES cell line E14 Pcgf6 / this study N/A Strain of origin 129P2/Ola
Mouse: ES cell line E14 Pcgf2/4 / this study N/A Strain of origin 129P2/Ola
Mouse: ES cell line E14 Pcgf1/2/4 / this study N/A Strain of origin 129P2/Ola
Mouse: ES cell line E14 Pcgf3/5/6/ this study N/A Strain of origin 129P2/Ola
Drosophila: S2 ATCC ATCC CRL-1963
Oligonucleotides
qPCR primer sets this study available upon request
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Recombinant DNA
pX459 2.0 this study; Table S1 Addgene #62988
pLKO.1 this study; Table S1 Addgene #8453
Chemicals, Peptides, and Recombinant Proteins
Leukemia inhibitory factor Pasini laboratory N/A
CHIR99021 Stemcell technologies Cat# 72052
PD0325901 Stemcell technologies Cat# 72182
Lipofectamine 2000 Invitrogen Cat# 11668027
Igepal Sigma-Aldrich Cat# I8896
EGS Sigma-Aldrich Cat# E3257
Deposited Data
E14-Cbx7 ChIP-Seq Morey et al., 2013 GEO: GSM1041373
E14-Rybp ChIP-Seq Morey et al., 2013 GEO: GSM1041375
E14-RNAPolII ChIP-Seq Riising et al., 2014 GEO: GSM1399506
E14-Mga ChIP-seq Stielow et al., 2018 ArrayExpress: E-MTAB-6007
E14-Kdm2b ChIP-seq Farcas et al., 2012 GEO: GSM1003694
E14-H2AK119Ub1 ChIP-Seq this study GEO: GSE122715
E14-H3K27m3 ChIP-Seq this study GEO: GSE122715
E14-H3K36m3 ChIP-Seq this study GEO: GSE122715
E14-H3K4m3 ChIP-Seq this study GEO: GSE122715
E14-Pcgf1 ChIP-Seq this study GEO: GSE122715
E14-Pcgf2 ChIP-Seq this study GEO: GSE122715
E14-Pcgf3 ChIP-Seq this study GEO: GSE122715
E14-Pcgf6 ChIP-Seq this study GEO: GSE122715
E14-Ring1b ChIP-Seq this study GEO: GSE122715
E14-Rybp ChIP-Seq this study GEO: GSE122715
E14-Suz12 ChIP-Seq this study GEO: GSE122715
E14-Usf1 ChIP-Seq this study GEO: GSE122715
E14-Wdr5 ChIP-Seq this study GEO: GSE122715
MgadHLH-Pcgf6 ChIP-Seq this study GEO: GSE122715
Pcgf124KO-H2AK119Ub1 ChIP-Seq this study GEO: GSE122715
Pcgf124KO-H3K27m3 ChIP-Seq this study GEO: GSE122715
Pcgf124KO-Ring1b ChIP-Seq this study GEO: GSE122715
Pcgf124KO-Suz12 ChIP-Seq this study GEO: GSE122715
Pcgf356KO-H2AK119Ub1 ChIP-Seq this study GEO: GSE122715
Pcgf356KO-H3K27m3 ChIP-Seq this study GEO: GSE122715
Pcgf356KO-Ring1b ChIP-Seq this study GEO: GSE122715
Pcgf356KO-Suz12 ChIP-Seq this study GEO: GSE122715
Pcgf1KO-H2AK119Ub1 ChIP-Seq this study GEO: GSE122715
Pcgf1KO-H3K27m3 ChIP-Seq this study GEO: GSE122715
Pcgf1KO-H3K36m3 ChIP-Seq this study GEO: GSE122715
Pcgf1KO-H3K4m3 ChIP-Seq this study GEO: GSE122715
Pcgf1KO-Pcgf1 ChIP-Seq this study GEO: GSE122715
Pcgf1KO-Pcgf2 ChIP-Seq this study GEO: GSE122715
Pcgf1KO-Pcgf3 ChIP-Seq this study GEO: GSE122715
Pcgf1KO-Pcgf6 ChIP-Seq this study GEO: GSE122715
Pcgf1KO-Ring1b ChIP-Seq this study GEO: GSE122715
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Pcgf1KO-Suz12 ChIP-Seq this study GEO: GSE122715
Pcgf24KO-H2AK119Ub1 ChIP-Seq this study GEO: GSE122715
Pcgf24KO-H3K27m3 ChIP-Seq this study GEO: GSE122715
Pcgf24KO-H3K36m3 ChIP-Seq this study GEO: GSE122715
Pcgf24KO-H3K4m3 ChIP-Seq this study GEO: GSE122715
Pcgf24KO-Pcgf1 ChIP-Seq this study GEO: GSE122715
Pcgf24KO-Pcgf2 ChIP-Seq this study GEO: GSE122715
Pcgf24KO-Pcgf3 ChIP-Seq this study GEO: GSE122715
Pcgf24KO-Pcgf6 ChIP-Seq this study GEO: GSE122715
Pcgf24KO-Ring1b ChIP-Seq this study GEO: GSE122715
Pcgf24KO-Suz12 ChIP-Seq this study GEO: GSE122715
Pcgf35KO-H2AK119Ub1 ChIP-Seq this study GEO: GSE122715
Pcgf35KO-H3K27m3 ChIP-Seq this study GEO: GSE122715
Pcgf35KO-H3K36m3 ChIP-Seq this study GEO: GSE122715
Pcgf35KO-H3K4m3 ChIP-Seq this study GEO: GSE122715
Pcgf35KO-Pcgf1 ChIP-Seq this study GEO: GSE122715
Pcgf35KO-Pcgf2 ChIP-Seq this study GEO: GSE122715
Pcgf35KO-Pcgf3 ChIP-Seq this study GEO: GSE122715
Pcgf35KO-Pcgf6 ChIP-Seq this study GEO: GSE122715
Pcgf35KO-Ring1b ChIP-Seq this study GEO: GSE122715
Pcgf35KO-Suz12 ChIP-Seq this study GEO: GSE122715
Pcgf6KO-H2AK119Ub1 ChIP-Seq this study GEO: GSE122715
Pcgf6KO-H3K27m3 ChIP-Seq this study GEO: GSE122715
Pcgf6KO-H3K36m3 ChIP-Seq this study GEO: GSE122715
Pcgf6KO-H3K4m3 ChIP-Seq this study GEO: GSE122715
Pcgf6KO-Pcgf1 ChIP-Seq this study GEO: GSE122715
Pcgf6KO-Pcgf2 ChIP-Seq this study GEO: GSE122715
Pcgf6KO-Pcgf3 ChIP-Seq this study GEO: GSE122715
Pcgf6KO-Pcgf6 ChIP-Seq this study GEO: GSE122715
Pcgf6KO-Ring1b ChIP-Seq this study GEO: GSE122715
Pcgf6KO-Suz12 ChIP-Seq this study GEO: GSE122715
RingdKO-Pcgf1 ChIP-Seq this study GEO: GSE122715
RingdKO-Pcgf2 ChIP-Seq this study GEO: GSE122715
RingdKO-Pcgf3 ChIP-Seq this study GEO: GSE122715
RingdKO-Pcgf6 ChIP-Seq this study GEO: GSE122715
RingFL-Pcgf1 ChIP-Seq this study GEO: GSE122715
RingFL-Pcgf2 ChIP-Seq this study GEO: GSE122715
RingFL-Pcgf3 ChIP-Seq this study GEO: GSE122715
RingFL-Pcgf6 ChIP-Seq this study GEO: GSE122715
shCtr-Pcgf3-rep1 ChIP-Seq this study GEO: GSE122715
shCtr-Pcgf3-rep2 ChIP-Seq this study GEO: GSE122715
shE2F6MgaDHLH-Pcgf6 ChIP-Seq this study GEO: GSE122715
shE2F6-Pcgf6 ChIP-Seq this study GEO: GSE122715
shMGA-Pcgf6 ChIP-Seq this study GEO: GSE122715
shUsf1-Pcgf3 ChIP-Seq this study GEO: GSE122715
shUsf2-Pcgf3 ChIP-Seq this study GEO: GSE122715
E14-Myc ChIP-Seq this study GEO: GSE122715
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Input-E14-293T-DX ChIP-Seq this study GEO: GSE122715
Input-E14-293T ChIP-Seq this study GEO: GSE122715
Input-E14-293T-Gal4P6 ChIP-Se this study GEO: GSE122715
Input-Pcgf1KO-293T-DX ChIP-Se this study GEO: GSE122715
Input-Pcgf1KO-293T ChIP-Seq this study GEO: GSE122715
Input-Pcgf1KO-293T-Gal4P6 ChI this study GEO: GSE122715
Input-Pcgf24KO-293T-DX ChIP-S this study GEO: GSE122715
Input-Pcgf24KO-293T ChIP-Seq this study GEO: GSE122715
Input-Pcgf24KO-293T-Gal4P6 Ch this study GEO: GSE122715
Input-Pcgf35KO-293T-DX ChIP-S this study GEO: GSE122715
Input-Pcgf35KO-293T ChIP-Seq this study GEO: GSE122715
Input-Pcgf35KO-293T-Gal4P6 Ch this study GEO: GSE122715
Input-Pcgf6KO-293T-DX ChIP-Se this study GEO: GSE122715
Input-Pcgf6KO-293T ChIP-Seq this study GEO: GSE122715
Input-Pcgf6KO-293T-Gal4P6 ChI this study GEO: GSE122715
Pcgf1-E14-293T ChIP-Seq this study GEO: GSE122715
Pcgf1-Pcgf1KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf1-Pcgf24KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf1-Pcgf35KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf1-Pcgf6KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf2-E14-293T ChIP-Seq this study GEO: GSE122715
Pcgf2-Pcgf1KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf2-Pcgf24KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf2-Pcgf35KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf2-Pcgf6KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf3-E14-rep2 ChIP-Seq this study GEO: GSE122715
Pcgf3-Pcgf1KO-rep2 ChIP-Seq this study GEO: GSE122715
Pcgf3-Pcgf24KO-rep2 ChIP-Seq this study GEO: GSE122715
Pcgf3-Pcgf35KO-rep2 ChIP-Seq this study GEO: GSE122715
Pcgf3-Pcgf6KO-rep2 ChIP-Seq this study GEO: GSE122715
Pcgf6-E14-293T ChIP-Seq this study GEO: GSE122715
Pcgf6-Pcgf1KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf6-Pcgf24KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf6-Pcgf35KO-293T ChIP-Seq this study GEO: GSE122715
Pcgf6-Pcgf6KO-293T ChIP-Seq this study GEO: GSE122715
E14-rep1 RNA-Seq this study GEO: GSE122715
E14-rep2 RNA-Seq this study GEO: GSE122715
P124KO-rep1 RNA-Seq this study GEO: GSE122715
P124KO-rep2 RNA-Seq this study GEO: GSE122715
P1KO-rep1 RNA-Seq this study GEO: GSE122715
P1KO-rep2 RNA-Seq this study GEO: GSE122715
P24KO-rep1 RNA-Seq this study GEO: GSE122715
P24KO-rep2 RNA-Seq this study GEO: GSE122715
P356KO-rep1 RNA-Seq this study GEO: GSE122715
P356KO-rep2 RNA-Seq this study GEO: GSE122715
P35KO-rep1 RNA-Seq this study GEO: GSE122715
P35KO-rep2 RNA-Seq this study GEO: GSE122715
P6KO-rep1 RNA-Seq this study GEO: GSE122715
P6KO-rep2 RNA-Seq this study GEO: GSE122715
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Software and Algorithms
Bowtie v1.2.2 Langmead et al., 2009 http://bowtie-bio.sourceforge.net/
index.shtml
PICARD N/A http://broadinstitute.github.io/picard
MACS2 v2.1.1 Zhang et al., 2008 https://github.com/taoliu/MACS
ChIPpeakAnno v3.15 Zhu et al., 2010 https://bioconductor.org/packages/
release/bioc/html/ChIPpeakAnno.html
VennDiagram v1.6.20 Chen and Boutros, 2011 https://www.rdocumentation.org/
packages/VennDiagram
ClusterProfiler Yu et al., 2012 http://bioconductor.org/packages/release/
bioc/html/clusterProfiler.html
HOMER Heinz et al., 2010 http://homer.ucsd.edu/
DeepTools 2.0 Ramı´rez et al., 2016 https://deeptools.readthedocs.io/en/latest/
TopHat v2.1.1 Trapnell et al., 2009 https://ccb.jhu.edu/software/tophat/
HTseq-count v0.8.0 Anders et al., 2015 https://www.huber.embl.de/HTSeq
FIMO Grant et al., 2011 http://meme-suite.org/doc/fimo.htmlCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Diego
Pasini (diego.pasini@ieo.it).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture and cell manipulation
All ESC lines (E14 and derivatives) were grown in a 0.1% gelatin-coated dish in GMEM supplemented with 15% FBS (Euroclone),
2 mM L-glutamine, 100 U/mL penicillin, 0.1 mg/mL streptomycin, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate,
50 mm b-mercaptoethanol (GIBCO), leukemia inhibitory factor, 3 mm GSK3b inhibitor (CHIR99021, STEMCELL Technologies),
1 mm MEK1/2 Inhibitor (PD0325901, STEMCELL Technologies).
For knockdown experiments, cells were transduced with 5 mg/mL polybrene and lentivirus particles delivering pLKO.1 vector ex-
pressing specific shRNAs for 16 hr; cells were then puromycin-selected (2 mg/mL) and grown for 72 hr prior harvesting.
To generate stable Pcgf KO cell lines, 10 mg pX459 2.0 plasmids (Addgene) encoding Cas9 and sgRNAs were transfected
using Lipofectamine 2000 (Invitrogen), according to the manufacturer’s instruction. Puromycin selection was performed for 30 hr
at 2 mg/mL, 2000 cells were seeded into a 15-cm dish, and clones were isolated 10 days later. Clones were screened by PCR for
genomic DNA, and Western Blot for protein lysates. PCR from positive clones were Sanger-sequenced to confirm genome editing.
For double- or triple KO cell lines, single KO clones were subjected to genome editing following the same procedure.
The Ring1A–/–;Ring1Bfl/fl;Rosa26::CreERT2 conditional mESC line was described previously (Endoh et al., 2008).
Gal4-DBD-Pcgf inducible cell lines were obtained by transfecting the specific pCDNA4/TO-Gal4-Pcgf vector into 293TREx
containing a stably integrated (Flp-In) 5 3 Gal4TK-Luc-neo construct described previously (Pasini et al., 2010). Transfected cells
were seeded at limiting dilutions, and isolated clones were screened by western blot for either Gal4 or Pcgf. The Gal4-DBD-Pcgf
chimera was expressed using by 1 mg/mL doxycycline (Sigma) medium added for 48 hr before collecting for ChIP and luciferase
reporter gene assay. For the latter, cells were lysed in passive lysis buffer (Promega) and then quantified with Bradford protein
assay (Bio-Rad), and the luciferase assay (Promega) was performed on a GloMax instrument (Promega) according to the manu-
facturer’s instructions.
Plasmid Generation
Coding sequences for mouse PCGF proteins were amplified from E14 cDNA and cloned into pCR8/Gateway/TOPO/TA (Invitrogen)
following the manufacturer’s protocol and sequenced verified. Different plasmids were subcloned in the desired compatible vectors
by Gateway technology using LR recombinase (Invitrogen). pGEX-4T-Pcgf was generated to produce GST fusion proteins; and
pCDNA4/TO-Gal4-Pcgf, for 293TREx Flp-In Gal4-Pcgf. For CRISPR/Cas9 genome editing, sgRNAs were cloned into the pX459
2.0 vector (Addgene). Details for sgRNAs and relative gene target are given in Table S1.Molecular Cell 74, 1037–1052.e1–e7, June 6, 2019 e5
Protein Purification and Antibody Generation
GST-PCGF fusion proteins were produced in E. coli (BL21) according to standard protocols, purified from crude lysates through fast-
flow glutathione Sepharose 4B resin (GE Healthcare), and eluted with elution buffer containing 10 mM reduced glutathione.
Eluted proteins were dialyzed against PBS, verified by SDS-PAGE Coomassie staining, and used to immunize rabbits (carried out
at Eurogentech). Antibodies from crude sera were immunoaffinity purified and tested for specificity.
Immunoblot, Immunoprecipitation, and Size-Exclusion Chromatography
Western blots were used to analyze lysates obtained with high-salt lysis buffer (20 mMTris-HCl, pH 7.6, 300mMNaCl, 10% glycerol,
0.2% [v/v] IGEPAL [Sigma-Aldrich]). For histone modification analyses, lysates were sonicated by Bioruptor (4 pulses at high inten-
sity, 30 s on/off).
For immunoprecipitation experiments, nuclei were purified using nuclear preparation buffer (10 mM Tris, pH 7.6, 2 mM MgCl2,
0.34 M sucrose, 0.25% [v/v] IGEPAL), lysed in high-salt lysis buffer supplemented with EDTA-free cocktail proteases inhibitors
(Roche), and incubated for 5 min at 37C with 25 U/mL benzonase (Merck); 200–500 mg nuclear lysates were incubated with 2 mg
of antibody for 2 hr at 4C, and protein Amagnetic beads (Invitrogen) were added for 45min to recover immunoprecipitated complex.
Beads were washed three times in high-salt buffer prior elution with loading sample buffer.
Size-exclusion chromatography of nuclear lysate was performed over a Superose 6 column (GE Healthcare) in 150 mM NaCl-salt
buffer mounted on a AKTA chromatography system (GE Healthcare).
For GAL4 immunoprecipitation, 293TRex GAL4-PCGFs nuclear extracts (3 mg) were incubated with 14 mg of anti GAL4 antibody
for 3 h at 4 C and then 40 ml slurry of Sepharose Protein G beads were added for 2 h at 4 C. IgG were used as negative control.
Beads were washed with nuclear extraction buffer and immunocomplexes were eluted in Laemmli buffer and resolved on NuPAGE
4%–12% precast protein gels (Invitrogen).
Size-exclusion chromatography of nuclear lysate was performed over a Superose 6 column (GE Healthcare) in 150 mM NaCl-salt
buffer mounted on a AKTA chromatography system (GE Healthcare).
Sample preparation and mass spectrometry analysis
Proteins from GAL4-PCGFs purification were separated by SDS–PAGE, using 4%–12% NuPAGE Novex Bis–Tris gels (Invitrogen)
and NuPAGE MES SDS running buffer (Invitrogen) and then stained with Coomassie Blue using InstantBlue Comassie (Expedeon).
Bands from gel were cut and digested with trypsin (Promega) and incubated for 16 h at 37C for protein digestion. Then, peptide
extraction was carried out and the resulting peptides mixture were combined, reduced in volume in a vacuum concentrator, desalted
and concentrated using StageTip (Proxeon Biosystems) columns, washed with 30 mL of 0,1% Formic acid (FA) and finally eluted with
40 mL of 80% MeCN in 0,1% FA. The samples were concentrated in vacuum concentrator (Eppendorf concentrator 5301) for 5 min
and peptides were dissolved in 7 mL of 0,1% FA. Approximately 5 mL of purified peptide mixture were analyzed on a LC–ESI–MS-MS
Q Exactive HF hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific). Full scan MS spectra were acquired in a
range of m/z 300–1800.
Peptides and proteins identification by database searching
Raw data files were analyzed using the peptide search engine Andromeda integrated into the MaxQuant software environment
(version 1.5.2.8) with the following parameters: uniprot_cp_hum_2017_01 as protein database, methionine oxidation, Protein
N-term Acetylation as variable modifications and carbamidomethylation as fixed, peptide false discovery rate (FDR) 0.01, minimum
peptides 2, at least 1 unique, minimum length peptide 6 amino acids. iBAQ intensity values as calculated by MaxQuant were used to
estimate relative abundance of proteins. LFQ ratio values are listed in Table S4.
ChIP and ChIP-seq
ChIP assays were carried out as described previously (Ferrari et al., 2014). Briefly, 1% formaldehyde cross-linked chromatin (1 mg)
was sonicated to an average size of 300–600 bp and incubated overnight at 4C with 1–8 mg of the indicated antibodies. For ChIP-
seq, column-purified DNA from a ChIP experiment was quantified using the Qubit dsDNA HS Assay Kit (Thermo Scientific, Q32854)
and 10 ngDNAwere processed at IEONGS core unit employing an automated platform (BeckmanCoulter) with the IlluminaChIP-seq
sample prep kit (IP-102-1001) and multiplexing oligonucleotide kit (PE400-1001). DNA libraries were quality-checked and quantified
on an automated sample processing workstation (Caliper Life Sciences) and used for cluster generation and sequencing by the
HiSeq 2000 (Illumina) at 50 bp read length. For PCGF1 ChIP, chromatin was crosslinked for 50 min at RT with 2 mM EGS (Sigma)
and then for 10 min with 1% formaldehyde. Quantitative ChIP experiments were performed relative to a reference exogenous
genome (ChIP-Rx) (Orlando et al., 2014). For histone modifications, a total of 5% ofDrosophila chromatin from S2 cell line was added
to each ChIP reaction, while for PCGF1 and PCGF2 a total of 50% of human chromatin from 293T cell line was used and, for PCGF6
ChIP-Rx, a total of 50% of human chromatin from 293T cell line expressing GAL4-PCGF6 fusion protein was added to each PCGF6
ChIP reaction. Spiked chromatins were sheared at a size of 200–300 bp.
For re-ChIP assays, immunoprecipitated DNA after the first ChIP was eluted with 50 mL of 10 mM DTT for 30 min at 37C and then
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ChIP-seq Analysis
Reads were aligned to the mouse reference genome mm9, or mm9 and dm6 for histone ChIP-Rx, or mm9 and hg38 for PCGF ChIP-
Rx samples, using Bowtie v1.2.2 (Langmead et al., 2009) with default parameters without allowing for multi-mapping (–m 1). PCR
duplicates were removed using PICARD (http://broadinstitute.github.io/picard/). Ambiguous reads mapping to both mm9 and
dm6 or hg38 were discarded. Peaks were called using MACS2 v2.1.1 (Zhang et al., 2008) with parameters -g mm–nomodel -p
1e-10 –B. Due to a higher IP efficiency in PCGF1 rep2, we used amore stringent p value cutoff (10e-30) to make the data comparable
to PCGF1 rep1. To avoid false positives, peakswere discarded if theywere in both PCGFwild-type samples and the respective PCGF
knockout samples. Then, peaks from biological replicates were merged together. A list containing the final PCGF peaks used in the
analyses can be found in Table S2. Genomic peak annotation was performed with the R package ChIPpeakAnno v3.15 (Zhu et al.,
2010), considering the region ± 2.5 kb around the TSS as the promoter. Scanning of PCGF6 targets for E-box and E2F sites down-
loaded from JASPAR (Khan et al., 2018) was done using FIMO (Grant et al., 2011) with default parameters. All downstream analyses
were performed considering peaks overlapping with promoter regions, unless otherwise specified. Peak lists were then transformed
to gene target lists (Table S3), and overlaps were performed using the R package VennDiagram v1.6.20 (Chen and Boutros, 2011).
Gene ontology analyses of PCGF targets were performed using the Bioconductor package clusterProfiler (Yu et al., 2012) setting as
threshold an adjusted p value and q-value of 0.01. Motif discovery was performed using HOMER (Heinz et al., 2010) with default pa-
rameters using as input the regions ± 25 bp around peak summits reported by MACS2.
For heatmap and intensity plot representation of ChIP-seq signal, BigWig files with input signal subtracted were generated using
the function bamCompare from deepTools 2.0 (Ramı´rez et al., 2016) with parameters–ratio subtract –bs 50–extendReads 200. To
normalize for differences in sample library size, a scaling factor for each sample was calculated as (1/total mapped reads)*1000000
and was applied during BigWig file generation with the parameter –scaleFactors from bamCompare. For ChIP-Rx samples the
scaling factor was calculated as described in (Orlando et al., 2014). Heatmaps were performed using the functions computeMatrix
followed by plotHeatmap from deepTools excluding blacklisted regions by ENCODE (Consortium, 2012) (Consortium, 2012). To ho-
mogenize the scale of all heatmaps, boxplots and intensity plots, signal intensity was scaled to 0–1 (represented by min-max in the
boxplot figures) by applying the formula 1/(P98 – P5) to all matrices generated by computeMatrix. In order to minimize any difference
in the IP and library preparation efficiencies between the two batches of biological replicates, the matrices generated from replicates
1 and replicates 2 were averaged and plotted as a single heatmap.
RNA-seq
RNA-seq was performed with minor modifications according to the SMART-seq2 protocol (Picelli et al., 2014). Briefly, poly-A
containing mRNA molecules from 2 mg of total extracted RNA were copied into first-strand cDNA by reverse transcription and tem-
plate-switching using oligo(dT) primers and an LNA-containing template-switching oligo (TSO); resulting cDNA was pre-amplified,
purified, and tagmented with in-house produced Tn5 transposase. cDNA fragments generated after tagmentation were gap-re-
paired, amplified by PCR, and cleaned to obtain the final cDNA library.
RNA-seq Analysis
Reads were aligned to the mouse reference genome mm9 using TopHat v2.1.1 (Trapnell et al., 2009) with parameters–no-coverage-
search and–library-type fr-unstranded. PCR duplicates were removed using PICARD (http://broadinstitute.github.io/picard/). Gene
counts were calculated using HTseq-count v0.8.0 (Anders et al., 2015) with parameters–stranded = no–mode = intersection-
nonempty using RefSeq mm9 annotation downloaded from UCSC. Differential expression analyses were performed using the R
package DESeq2 v1.20 (Love et al., 2014) using default parameters. Genes with an absolute log2 fold change of 2 and FDR <
0.05 were considered as differentially expressed (Table S5). Gene ontology analysis of differentially expressed genes was performed
using the Bioconductor package clusterProfiler (Yu et al., 2012) with default parameters. Full results of gene ontology analyses are
provided in Table S6.
Quantitative Real-Time PCR
Total RNAwas extracted from cells using the Quick-RNA kit (Zymo) according tomanufacturer’s protocol. RNAwas used to generate
cDNA by reverse transcriptase PCR using the M-MuLV Reverse Transcriptase (Promega). Relative mRNA expression levels were
determined using the Go-Taq SYBR Green (Promega) on a Bio-Rad Real-Time PCR System with selected primer pairs. Expression
levels were normalized toGapdh, used as a control housekeeping gene, and computed as described previously (Ferrari et al., 2014).
Data availability
ChIP-seq and RNA-seq datasets are available at GEO database this accession number: GSE122715Molecular Cell 74, 1037–1052.e1–e7, June 6, 2019 e7
